外泌体在骨髓间充质干细胞骨向分化及其在牙周再生中的研究进展

doi:10.13591/j.cnki.kqyx.2022.08.013

摘要/Abstract

摘要： 外泌体是多种细胞在生理或病理状态下分泌到细胞外的纳米级囊泡,富含蛋白质、核酸、脂质等生物活性物质,是细胞间信息交流传递和物质交换转移的重要介质。研究证实,外泌体可通过蛋白、miRNAs等调控干细胞的增殖、分化,在免疫应答、炎症反应等过程中均发挥重要的调节作用。本文就炎性环境下不同细胞来源的外泌体生物学性能及其在成骨分化中的作用作一综述,以期为牙周炎所致骨缺损的治疗方法提供参考。

关键词: 外泌体, 骨髓间充质干细胞, 成骨分化, 牙周炎, 炎症

Abstract: Exosomes are nano vesicles secreted by a variety of cells under physiological or pathological conditions. Rich in bioactive substances such as protein, nucleic acid and lipid, they are an important medium for information exchange and material transfer between cells. Studies have confirmed that exosomes can regulate the proliferation and differentiation of stem cells through proteins and miRNAs, and play an important regulatory role in the process of immune response and inflammatory response. This paper reviews the biological properties of exosomes from different cell sources in inflammatory environment and their role in osteogenic differentiation, so as to provide reference for the treatment of bone defect caused by periodontitis.

Key words: exosome, bone marrow mesenchymal stem cell, osteogenic differentiation, periodontitis, inflammation

中图分类号:

R781.4

张淑婷, 吴亚星, 刘翠翠, 李晨晨, 张静. 外泌体在骨髓间充质干细胞骨向分化及其在牙周再生中的研究进展[J]. 口腔医学, 2022, 42(8): 741-744.

ZHANG Shuting, WU Yaxing, LIU Cuicui, LI Chenchen, ZHANG Jing. Research progress of exosomes in osteogenic differentiation of bone marrow mesenchymal stem cells and in periodontal regeneration[J]. Stomatology, 2022, 42(8): 741-744.

参考文献

[1] Gasner NS, Schure RS. Periodontal disease[M]. Florida: StatPearls Publishing, 2021.
[2] Mann J, Bernstein Y, Findler M. Periodontal disease and its prevention, by traditional and new avenues[J]. Exp Ther Med, 2020, 19(2):1504-1506.
[3] Nuñez J, Vignoletti F, Caffesse RG, et al. Cellular therapy in periodontal regeneration[J]. Periodontol 2000, 2019, 79(1):107-116.
[4] Xu XY, Li X, Wang J, et al. Concise review:Periodontal tissue regeneration using stem cells:Strategies and translational considerations[J]. Stem Cells Transl Med, 2019, 8(4):392-403.
[5] Liu GL, David BT, Trawczynski M, et al. Advances in pluripotent stem cells:History, mechanisms, technologies, and applications[J]. Stem Cell Rev Rep, 2020, 16(1):3-32.
[6] Bahmad HF, Elajami MK, Daouk R, et al. Stem cells:In sickness and in health[J]. Curr Stem Cell Res Ther, 2021, 16(3):262-276.
[7] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478):eaau6977.
[8] Ha DH, Kim HK, Lee J,et al. Mesenchymal stem/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration[J]. Cells, 2020, 9(5):1157.
[9] Ratajczak MZ, Ratajczak J. Extracellular microvesicles/exosomes:Discovery, disbelief, acceptance, and the future?[J]. Leukemia, 2020, 34(12):3126-3135.
[10] Chan BD, Wong WY, Lee MML, et al. Exosomes in inflammation and inflammatory disease[J]. Proteomics, 2019, 19(8):e1800149.
[11] Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes[J]. Int Immunopharmacol, 2021, 97:107823.
[12] Shevyrev D, Tereshchenko V. Treg heterogeneity, function, and homeostasis[J]. Front Immunol, 2020, 10:3100.
[13] Bryniarski K, Ptak W, Jayakumar A, et al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity[J]. J Allergy Clin Immunol, 2013, 132(1):170-181.
[14] Ferreira LMR, Muller YD, Bluestone JA, et al. Next-generation regulatory T cell therapy[J]. Nat Rev Drug Discov, 2019, 18(10):749-769.
[15] Liu Y, Yang RL, Shi ST. Systemic infusion of mesenchymal stem cells improves cell-based bone regeneration via upregulation of regulatory T cells[J]. Tissue Eng Part A, 2015, 21(3/4):498-509.
[16] Chen L, Xiong Y, Hu YQ, et al. Regulatory T cell-exosomal miR-142-3p promotes angiogenesis and osteogenesis via TGFBR1/SMAD2 inhibition to accelerate fracture repair[J].Chem Eng J, 2022, 427:131419.
[17] Yang C, Wang W, Zhu KC, et al. Lithium chloride with immunomodulatory function for regulating titanium nanoparticle-stimulated inflammatory response and accelerating osteogenesis through suppression of MAPK signaling pathway[J]. Int J Nanomedicine, 2019, 14:7475-7488.
[18] Viola A, Munari F, Sánchez-Rodríguez R, et al. The metabolic signature of macrophage responses[J]. Front Immunol, 2019, 10:1462.
[19] Li SX, Qiu JX, Qin L, et al. NOD2 negatively regulated titanium particle-induced osteolysis in mice[J]. Biomater Sci, 2019, 7(7):2702-2715.
[20] Xiong Y, Chen L, Yan CC, et al. M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3[J]. J Nanobiotechnology, 2020, 18(1):66.
[21] 张程,包丽荣,杨于桃,等.M2巨噬细胞外泌体对高糖高胰岛素条件下小鼠骨髓间充质干细胞成骨分化的影响[J].四川大学学报(医学版),2022,53(1):63-70.
[22] Bao CC, He CQ. The role and therapeutic potential of MSC-derived exosomes in osteoarthritis[J]. Arch BiochemBiophys, 2021, 710:109002.
[23] Huang B, Su YW, Shen EP, et al. Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model[J]. Life Sci, 2021, 272:119208.
[24] Fan L, Guan PF, Xiao CR, et al. Exosome-functionalized polyetheretherketone-based implant with immunomodulatory property for enhancing osseointegration[J]. Bioact Mater, 2021, 6(9):2754-2766.
[25] Ni ZH, Zhou SR, Li S, et al. Exosomes:roles and therapeutic potential in osteoarthritis[J]. Bone Res, 2020, 8:25.
[26] Wei Y, Tang CZ, Zhang JL, et al. Extracellular vesicles derived from the mid-to-late stage of osteoblast differentiation markedly enhance osteogenesis in vitro and in vivo[J]. BiochemBiophys Res Commun, 2019, 514(1):252-258.
[27] Cui YZ, Luan J, Li HY, et al. Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression[J]. FEBS Lett, 2016, 590(1):185-192.
[28] Yuan FL, Wu QY, Miao ZN, et al. Osteoclast-derived extracell-ular vesicles:Novel regulators of osteoclastogenesis and osteoclast-osteoblasts communication in bone remodeling[J]. Front Physiol, 2018, 9:628.
[29] Liang MM, Yin XF, Zhang S, et al. Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1[J]. Mol Ther Nucleic Acids, 2021, 23:1191-1203.
[30] Stessuk T, Husch J, Hermens IA, et al. Osteogenic differentiation driven by osteoclasts and macrophages[J]. J Immunol Regen Med, 2021, 12:100044.
[31] Mende W, Götzl R, Kubo Y, et al. The role of adipose stem cells in bone regeneration and bone tissue engineering[J]. Cells, 2021, 10(5):975.
[32] Chen S, Tang YM, Liu YS, et al. Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration[J]. Cell Prolif, 2019, 52(5):e12669.
[33] Li WY, Liu YS, Zhang P, et al. Tissue-engineered bone immobilized with human adipose stem cells-derived exosomes promotes bone regeneration[J]. ACS Appl Mater Interfaces, 2018, 10(6):5240-5254.
[34] Kang Y, Xu C, Meng LA, et al. Exosome-functionalized magnesium-organic framework-based scaffolds with osteogenic, angiogenic and anti-inflammatory properties for accelerated bone regeneration[J].Bioact Mater, 2022,18:26-41.
[35] Santonocito S, Polizzi A, Palazzo G, et al. The emerging role of microRNA in periodontitis:Pathophysiology, clinical potential and future molecular perspectives[J]. Int J Mol Sci, 2021, 22(11):5456.
[36] Shen ZS, Kuang SH, Zhang Y, et al. Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism[J]. Bioact Mater, 2020, 5(4):1113-1126.
[37] 张璐, 王凯欣, 王晓春. 外泌体在口腔组织修复与再生中的研究进展[J]. 口腔医学, 2020, 40(12):1152-1156.
[38] Chew JRJ, Chuah SJ, Teo KYW, et al. Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration[J]. Acta Biomater, 2019, 89:252-264.
[39] Wang R, Ji QX, Meng CD,et al. Role of gingival mesenchymal stem cell exosomes in macrophage polarization under inflammatory conditions[J]. Int Immunopharmacol, 2020, 81:106030.